Clinical Infectious Diseases
Search the journal

This title is part of a longer publication history. The full run of this journal will be searched.

TITLE HISTORY A title history is the publication history of a journal and includes a listing of the family of related journals. The most common relationship is to a previous and/or continuing title, where a journal continues publishing with a change to its official title. Other common relationships include a journal that is a supplement to another journal, a journal that is absorbed into another journal, a journal that splits into two or more new journals, or two or more journals that merge to form a new journal. For each of these related journals, the title history lists the dates published.
  1. 1992-2018 • Clinical Infectious Diseases
  2. 1979-1991 • Reviews of Infectious Diseases
Clinical Infectious Diseases publishes clinically relevant articles on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. Special sections include articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. In addition, the journal features highly focused brief reports, review articles, editorials, commentaries, and supplements. Published for the Infectious Diseases Society of America.
Journal information
All Issues
2010s
  1. 2018 (Vol. 67)
    1. No. 12 15 December 2018 pp. i-iv, 1803-1961, e95-e104
    2. Supplement 3: Science-based Dosing of Second Line Antituberculosis Agents for TB Programs 15 December 2018 pp. S267-S367
    3. No. 11 1 December 2018 pp. i-iv, 1643-1801
    4. Supplement 2: Current Status and Challenge of Antimicrobial Resistance in China 1 December 2018 pp. S127-S265
    5. No. 10 15 November 2018 pp. i-iv, 1477-1641
    6. Supplement 1: Polio Endgame and Beyond: Vaccine Choices, Transmission Dynamics, and Surveillance Implications 15 November 2018 pp. S1-S126
    7. No. 9 1 November 2018 pp. i-iv, 1315-1476
    8. No. 8 15 October 2018 pp. i-iv, 1153-1313
    9. No. 7 1 October 2018 pp. i-iv, 991-1151
    10. No. 6 15 September 2018 pp. i-iv, 813-989, e1-e94
    11. No. 5 1 September 2018 pp. i-iv, 649-812
    12. No. 4 15 August 2018 pp. i-iv, 485-647
    13. No. 3 1 August 2018 pp. i-iv, 323-483
    14. No. 2 15 July 2018 pp. i-iv, 161-322
    15. No. 1 1 July 2018 pp. i-iv, 1-160
  2. 2018 (Vol. 66)
    1. No. 12 15 June 2018 pp. i-iv, 1823-1983
    2. Supplement 4: Reaching the 2020 Goals for Nine Neglected Tropical Diseases 15 June 2018 pp. S237-S308
    3. No. 11 1 June 2018 pp. i-iv, 1651-1822
    4. No. 10 15 May 2018 pp. i-iv, 1487-1649
    5. No. 9 1 May 2018 pp. i-iv, 1323-1486
    6. No. 8 15 April 2018 pp. i-iv, 1159-1322, e49-e75
    7. Supplement 3: Adolescent Voluntary Medical Male Circumscision: Vital Intervention Yet Improvements Needed 15 April 2018 pp. S161-S235
    8. No. 7 1 April 2018 pp. i-iv, 987-1158, e1-e48
    9. Supplement 2: Advanced HIV Disease 1 April 2018 pp. S103-S159
    10. No. 6 15 March 2018 pp. i-iv, 815-985
    11. No. 5 1 March 2018 pp. i-iv, 645-813
    12. No. 4 15 February 2018 pp. i-iv, 489-644
    13. No. 3 1 February 2018 pp. i-iv, 321-487
    14. No. 2 15 January 2018 pp. i-iv, 163-320
    15. Supplement 1: Botulism 15 January 2018 pp. S1-S102
    16. No. 1 1 January 2018 pp. i-iv, 1-161
  3. 2017 (Vol. 65)
    1. No. 12 15 December 2017 pp. i-iv, 1963-2161, e38-e80
    2. No. 11 1 December 2017 pp. i-iv, 1773-1961
    3. No. 10 15 November 2017 pp. i-iv, 1601-1771, e1-e37
    4. No. 9 1 November 2017 pp. i-iv, 1437-1599
    5. No. 8 15 October 2017 pp. i-iv, 1253-1436
    6. No. 7 1 October 2017 pp. i-iv, 1059-1252
    7. No. 6 15 September 2017 pp. i-iv, 877-1058
    8. No. 5 1 September 2017 pp. i-iv, 709-876
    9. No. 4 15 August 2017 pp. i-iv, 535-708
    10. Supplement 1. Emerging Concepts and Strategies in Clinical Microbiology and Infectious Diseases 15 August 2017 pp. S1-S88
    11. No. 3 1 August 2017 pp. i-iv, 359-534
    12. No. 2 15 July 2017 pp. i-iv, 183-358
    13. No. 1 1 July 2017 pp. i-iv, 1-182
  4. 2017 (Vol. 64)
    1. No. 12 15 June 2017 pp. i-iv, 1637-1806
    2. Supplement 3. Pneumonia Etiology Research for Child Health (PERCH): Foundational Basis for the Primary Etiology Results 15 June 2017 pp. S179-S386
    3. No. 11 1 June 2017 pp. i-iv, 1471-1636
    4. No. 10 15 May 2017 pp. i-iv, 1299-1470
    5. Supplement 2. Infection Prevention in Asia Pacific 15 May 2017 pp. S49-S178
    6. No. 9 1 May 2017 pp. i-iv, 1147-1298
    7. No. 8 15 April 2017 pp. i-iv, 989-1146
    8. No. 7 1 April 2017 pp. i-iv, 823-988
    9. No. 6 15 March 2017 pp. i-iv, 701-822
    10. Supplement 1. Antibacterial Resistance Leadership Group (ARLG): Productivity and Innovation 15 March 2017 pp. S1-S48
    11. No. 5 1 March 2017 pp. i-iv, 537-700
    12. No. 4 15 February 2017 pp. i-iv, 393-536
    13. No. 3 1 February 2017 pp. i-iv, 237-392
    14. No. 2 15 January 2017 pp. i-iv, 111-236
    15. No. 1 1 January 2017 pp. i-iv, 1-110
  5. 2016 (Vol. 63)
    1. No. 12 15 December 2016 pp. i-iv, 1537-1686
    2. Supplement 5. Malaria in Highly Endemic Areas: Improving Control Through Diagnosis, Artemisinin Combination Therapy, and Rectal Artesunate Treatment 15 December 2016 pp. S245-S322
    3. No. 11 1 December 2016 pp. i-iv, 1399-1536
    4. Supplement 4. Infant Pertussis Disease Burden in the Context of Maternal Immunization Strategies 1 December 2016 pp. S117-S244
    5. No. 10 15 November 2016 pp. i-iv, 1273-1398
    6. No. 9 1 November 2016 pp. i-vi, 1151-1272
    7. Supplement 3. A Development Paradigm for Novel Combination Regimens for Multidrug-Resistant and Drug-Susceptible Tuberculosis in Children: FLAME for Work and Play 1 November 2016 pp. S61-S116
    8. No. 8 15 October 2016 pp. i-iv, 999-1150
    9. No. 7 1 October 2016 pp. i-iv, 853-998
    10. No. 6 15 September 2016 pp. i-iv, 717-852
    11. No. 5 1 September 2016 pp. i-iv, 575-716
    12. No. 4 15 August 2016 pp. i-iv, 433-574
    13. Supplement 2. Facilitating Antibacterial Drug Development in a Time of Great Need 15 August 2016 pp. S24-S59
    14. No. 3 1 August 2016 pp. i-iv, 291-432
    15. No. 2 15 July 2016 pp. i-iv, 151-290
    16. Supplement 1. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy 15 July 2016 pp. S1-S24
    17. No. 1 1 July 2016 pp. i-iv, 1-150
  6. 2016 (Vol. 62)
    1. No. 12 15 June 2016 pp. i-iv, 1471-1622
    2. No. 11 1 June 2016 pp. i-iv, 1329-1470
    3. Supplement 4. Hepatitis B 1 June 2016 pp. S281-S326
    4. No. 10 15 May 2016 pp. i-iv, 1197-1328
    5. Supplement 3. Healthcare Workers and Tuberculosis Prevention 15 May 2016 pp. S229-S280
    6. No. 9 1 May 2016 pp. i-iv, 1059-1196
    7. Supplement 2. Health Benefits of Rotavirus Vaccination in Developing Countries 1 May 2016 pp. S91-S228
    8. No. 8 15 April 2016 pp. i-iv, 957-1058
    9. No. 7 1 April 2016 pp. i-iv, 817-956
    10. No. 6 15 March 2016 pp. i-iv, 675-816
    11. Supplement 1. Typhoid Fever Surveillance in Africa Program (TSAP) 15 March 2016 pp. S1-S90
    12. No. 5 1 March 2016 pp. i-iv, 531-674
    13. No. 4 15 February 2016 pp. i-iv, 409-530
    14. No. 3 1 February 2016 pp. i-iv, 273-408
    15. No. 2 15 January 2016 pp. i-iv, 139-272
    16. No. 1 1 January 2016 pp. i-iv, 1-138
  7. 2015 (Vol. 61)
    1. No. 12 15 December 2015 pp. i-iv, 1771-1896
    2. Supplement 8. Evidence Papers for the CDC Sexually Transmitted Diseases Treatment Guidelines 15 December 2015 pp. S759-S874
    3. Supplement 7. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial 15 December 2015 pp. S685-S758
    4. No. 11 1 December 2015 pp. i-vi, 1637-1770
    5. Supplement 6. Advances and New Directions for Echinocandins 1 December 2015 pp. S601-S684
    6. No. 10 15 November 2015 pp. i-iv, 1495-1636
    7. Supplement 5. The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group A Meningococcal Conjugate Vaccine for Africa 15 November 2015 pp. S387-S600
    8. No. 9 1 November 2015 pp. i-iv, 1355-1494
    9. Supplement 4. Invasive Salmonella Disease in Africa 1 November 2015 pp. S235-S386
    10. No. 8 15 October 2015 pp. i-iv, 1217-1354
    11. Supplement 3. Advances in Tuberculosis Research: A Blueprint for Opportunities 15 October 2015 pp. S95-S234
    12. No. 7 1 October 2015 pp. i-iv, 1035-1216
    13. No. 6 15 September 2015 pp. i-iv, 859-1034
    14. Supplement 2. Telavancin: Treatment for Gram-positive Infections–New Perspectives on In Vitro and Clinical Data 15 September 2015 pp. S35-S94
    15. No. 5 1 September 2015 pp. i-iv, 669-858
    16. No. 4 15 August 2015 pp. i-iv, 491-668
    17. Supplement 1. An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model 15 August 2015 pp. S1-S34
    18. No. 3 1 August 2015 pp. i-iv, 299-490
    19. No. 2 15 July 2015 pp. i-iv, 145-298
    20. No. 1 1 July 2015 pp. i-iv, 1-144
  8. 2015 (Vol. 60)
    1. No. 12 15 June 2015 pp. i-iv, 1737-1880
    2. No. 11 1 June 2015 pp. i-iv, 1591-1736
    3. Supplement 3. HIV Postexposure Prophylaxis 1 June 2015 pp. S159-S212
    4. No. 10 15 May 2015 pp. i-iv, 1451-1590
    5. Supplement 2. Probiotics: Added Supplementary Value in Clostridium difficile Infection 15 May 2015 pp. S65-S158
    6. No. 9 1 May 2015 pp. i-iv, 1295-1450
    7. Supplement 1. CDC Modeling Efforts in Response to a Potential Public Health Emergency: Influenza A(H7N9) as an Example 1 May 2015 pp. S1-S64
    8. No. 8 15 April 2015 pp. i-iv, 1145-1294
    9. No. 7 1 April 2015 pp. i-iv, 979-1144
    10. No. 6 15 March 2015 pp. i-iv, 831-978
    11. No. 5 1 March 2015 pp. i-iv, 677-830
    12. No. 4 15 February 2015 pp. i-iv, 499-676
    13. No. 3 1 February 2015 pp. i-iv, 333-498
    14. No. 2 15 January 2015 pp. i-iv, 177-332
    15. No. 1 1 January 2015 pp. i-iv, 1-176
  9. 2014 (Vol. 59)
    1. No. 12 15 December 2014 pp. i-iv, 1657-1812
    2. Supplement 7. Including Pregnant Women in Clinical Trials of Antimicrobials and Vaccines 15 December 2014 pp. S395-S444
    3. No. 11 1 December 2014 pp. i-iv, 1511-1656
    4. Supplement 6. Minocycline for the Treatment of Multidrug-Resistant Acinetobacter baumannii 1 December 2014 pp. S365-S393
    5. No. 10 15 November 2014 pp. i-iv, 1353-1510
    6. Supplement 5. The Third Infections in Cancer Symposium 15 November 2014 pp. S331-S364
    7. No. 9 1 November 2014 pp. i-vi, 1203-1352
    8. Supplement 4. The Malnutrition and Enteric Disease Study (MAL-ED): Understanding the Consequences for Child Health and Development 1 November 2014 pp. S193-S330
    9. No. 8 15 October 2014 pp. i-iv, 1049-1202
    10. Supplement 3. Antimicrobial Stewardship: Patients Over Process 15 October 2014 pp. S93-S192
    11. No. 7 1 October 2014 pp. i-iv, 913-1048
    12. No. 6 15 September 2014 pp. i-iv, 755-912
    13. Supplement 2. The John Bartlett Festschrift: Celebrating a Career in Medicine 15 September 2014 pp. S61-S92
    14. No. 5 1 September 2014 pp. i-iv, 615-754
    15. No. 4 15 August 2014 pp. i-iv, 465-614
    16. No. 3 1 August 2014 pp. i-iv, 325-464
    17. No. 2 15 July 2014 pp. i-iv, 147-324
    18. No. 1 1 July 2014 pp. i-v, 1-146
    19. Supplement 1. Controlling the HIV Epidemic With Antiretrovirals 1 July 2014 pp. S1-S60
  10. 2014 (Vol. 58)
    1. No. 12 15 June 2014 pp. i-iv, 1649-1792
    2. No. 11 1 June 2014 pp. i-iv, 1497-1648
    3. No. 10 15 May 2014 pp. i-iv, 1347-1496
    4. No. 9 1 May 2014 pp. i-iv, 1205-1346
    5. No. 8 15 April 2014 pp. i-iv, 1047-1204
    6. No. 7 1 April 2014 pp. i-v, 909-1046
    7. No. 6 15 March 2014 pp. i-iv, 755-908
    8. No. 5 1 March 2014 pp. i-iv, 609-754
    9. No. 4 15 February 2014 pp. i-iv, 449-608
    10. No. 3 1 February 2014 pp. i-iv, 309-448
    11. No. 2 15 January 2014 pp. i-iv, 147-308, e39-e43
    12. No. 1 1 January 2014 pp. i-iv, 1-146
    13. Supplement 1. Tedizolid – A Novel Oxazolidinone for Gram-Positive Infections 1 January 2014 pp. S1-S58
  11. 2013 (Vol. 57)
    1. No. 12 15 December 2013 pp. i-iv, 1665-1802
    2. Supplement 4. Prenatal Therapy of Congenital Cytomegalovirus Infection 15 December 2013 pp. S171-S200
    3. No. 11 1 December 2013 pp. i-iv, 1511-1664
    4. Supplement 3. Better Tests, Better Care: Improved Diagnostics for Infectious Diseases 1 December 2013 pp. S139-S170
    5. No. 10 15 November 2013 pp. i-iv, 1373-1510
    6. No. 9 1 November 2013 pp. i-vi, 1225-1372
    7. No. 8 15 October 2013 pp. i-iv, 1069-1224
    8. No. 7 1 October 2013 pp. i-iv, 923-1068
    9. No. 6 15 September 2013 pp. i-iv, 781-922
    10. No. 5 1 September 2013 pp. i-iv, 631-780
    11. No. 4 15 August 2013 pp. i-iv, 485-630
    12. Supplement 2. Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward 15 August 2013 pp. S29-S138
    13. No. 3 1 August 2013 pp. i-iv, 333-484
    14. No. 2 15 July 2013 pp. i-iv, 167-332
    15. Supplement 1. The Emergence of Influenza A (H2N2) v Virus: What We Learned From the First Wave, July 2011–April 2012 15 July 2013 pp. S1-S27
    16. No. 1 1 July 2013 pp. i-vi, 1-166
  12. 2013 (Vol. 56)
    1. No. 12 15 June 2013 pp. i-iv, 1685-1852
    2. No. 11 1 June 2013 pp. i-iv, 1519-1684
    3. No. 10 15 May 2013 pp. i-iv, 1363-1518
    4. No. 9 1 May 2013 pp. i-iv, 1197-1362
    5. No. 8 15 April 2013 pp. i-iv, 1067-1196
    6. No. 7 1 April 2013 pp. i-iv, 913-1066
    7. No. 6 15 March 2013 pp. i-iv, 755-912
    8. No. 5 1 March 2013 pp. i-iv, 621-754
    9. No. 4 15 February 2013 pp. i-vi, 471-620
    10. No. 3 1 February 2013 pp. i-iv, 315-470
    11. No. 2 15 January 2013 pp. i-iv, 171-314
    12. No. 1 1 January 2013 pp. i-iv, 1-170
  13. 2012 (Vol. 55)
    1. No. 12 15 December 2012 pp. i-iv, 1591-1755
    2. Supplement 4. The Global Enteric Multicenter Study (GEMS) 15 December 2012 pp.
    3. No. 11 1 December 2012 pp. i-iv, vii, 1441-1590
    4. No. 10 15 November 2012 pp. i-iv, 1279-1439
    5. No. 9 1 November 2012 pp. i-iv, 1171-1277
    6. No. 8 15 October 2012 pp. i-iv, 1031-1170
    7. No. 7 1 October 2012 pp. i-iv, 897-1029
    8. No. 6 15 September 2012 pp. i-iv, 753-895
    9. Supplement 3. Ceftaroline Applications for Therapy in the United States 15 September 2012 pp. S171-S214
    10. No. 5 1 September 2012 pp. i-iv, 615-752
    11. No. 4 15 August 2012 pp. i-iv, 479-614
    12. No. 3 1 August 2012 pp. i-iv, 313-478
    13. Supplement 2. Fidaxomicin and the Evolving Approach to the Treatment of Clostridium difficile Infection 1 August 2012 pp. S65-S170
    14. No. 2 15 July 2012 pp. i-iv, 169-312
    15. Supplement 1. The Evolving Paradigm of Hepatitis C 15 July 2012 pp. S1-S64
    16. No. 1 1 July 2012 pp. i-iv, 1-168
  14. 2012 (Vol. 54)
    1. No. 12 15 June 2012 pp. i-iv, 1679-1822
    2. No. 11 1 June 2012 pp. i-iv, 1523-1615, 1516-1678
    3. Supplement 5. Studies From the Foodborne Diseases Active Surveillance Network 1 June 2012 pp. S381-S504
    4. No. 10 15 May 2012 pp. i-iv, 1381-1522
    5. Supplement 4. The World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: Global, Regional, and Country Progress 15 May 2012 pp. S245-S380
    6. No. 9 1 May 2012 pp. i-iv, 1221-1380
    7. No. 8 15 April 2012 pp. i-iv, 1041-1220
    8. Supplement 3. Oritavancin for the Treatment of Serious Gram-Positive Infections 15 April 2012 pp. S201-S244
    9. No. 7 1 April 2012 pp. i-iv, 891-1040
    10. Supplement 2. Pneumonia Etiology Research for Child Health 1 April 2012 pp. S87-S200
    11. No. 6 15 March 2012 pp. i-iv, 743-890
    12. No. 5 1 March 2012 pp. i-iv, 585-742
    13. No. 4 15 February 2012 pp. i-iv, 455-583
    14. No. 3 1 February 2012 pp. i-iv, 311-454
    15. No. 2 15 January 2012 pp. i-iv, 157-309
    16. No. 1 1 January 2012 pp. i-iv, 1-156
    17. Supplement 1. Advances Against Mucormycosis: A Tribute to the Memory and Courage of Hank Schueler 1 February 2012 pp. S1-S85
  15. 2011 (Vol. 53)
    1. No. 12 15 December 2011 pp. i-iv, 1173-1318
    2. Supplement 3. Sexually Transmitted Disease: Treatment Guidelines 15 December 2011 pp. S59-S172
    3. No. 11 1 December 2011 pp. i-v, 1043-1172
    4. No. 10 15 November 2011 pp. i-iv, 969-1042
    5. No. 9 1 November 2011 pp. i-iv, 853-968
    6. No. 8 15 October 2011 pp. i-iv, 751-852
    7. No. 7 1 October 2011 pp. i-ii, 617-750
    8. No. 6 15 September 2011 pp. i-iv, 503-616
    9. Supplement 2. Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections 15 September 2011 pp. S31-S58
    10. No. 5 1 September 2011 pp. i-iv, 405-502
    11. No. 4 15 August 2011 pp. i-iv, 321-404
    12. Supplement 1. Antimicrobial Stewardship for the Community Hospital: Practical Tools & Techniques for Implementation 15 August 2011 pp. S1-S30
    13. No. 3 1 August 2011 pp. i-iv, 215-320
    14. No. 2 15 July 2011 pp. i-iv, 107-214
    15. No. 1 1 July 2011 pp. i-iv, 1-105
  16. 2011 (Vol. 52)
    1. No. 12 15 June 2011 pp. i-iv, 1399-1482
    2. No. 11 1 June 2011 pp. i-iv, 1283-1397
    3. Supplement 7: Fusidic Acid Enters the United States 1 June 2011 pp. S467-S546
    4. No. 10 15 May 2011 pp. i-iv, 1203-1282
    5. Supplement 6: Candida Urinary Tract Infections 15 May 2011 pp. S429-S466
    6. No. 9 1 May 2011 pp. i-iv, 1087-1202
    7. Supplement 4: Workshop on Molecular Diagnostics for Respiratory Tract Infections 1 May 2011 pp. S277-S395
    8. Supplement 5: Combating Antimicrobial Resistance: Policy Recommendations to Save Lives 1 May 2011 pp. S397-S428
    9. No. 8 15 April 2011 pp. i-iv, 969-1085
    10. No. 7 1 April 2011 pp. i-iv, 837-967
    11. No. 6 15 March 2011 pp. i-iv, 695-835
    12. No. 5 1 March 2011 pp. i-iv, 561-693
    13. No. 4 15 February 2011 pp. i-iv, 427-559
    14. No. 3 1 February 2011 pp. i-iv, 285-426
    15. Supplement 3: The Need for a New Lyme Disease Vaccine 1 February 2011 pp. S247-S275
    16. No. 2 15 January 2011 pp. i-iv, 157-284
    17. Supplement 2: Linkage, Engagement, and Retention in HIV Care 15 January 2011 pp. S205-S246
    18. No. 1 1 January 2011 pp. i-v, 1-155
    19. Supplement 1: The 2009 H1N1 Influenza Pandemic: Field and Epidemiologic Investigations 1 January 2011 pp. S1-S204
  17. 2010 (Vol. 51)
    1. No. 12 15 December 2010 pp. i-v, 1355-1482
    2. No. 11 1 December 2010 pp. i-iv, 1229-1354
    3. No. 10 15 November 2010 pp. i-iv, 1115-1228
    4. No. 9 1 November 2010 pp. i-vi, 997-1114
    5. No. 8 15 October 2010 pp. i-iv, 879-996
    6. No. 7 1 October 2010 pp. i-iv, 761-878
    7. No. 6 15 September 2010 pp. i-iv, 641-760
    8. Supplement 2. Meeting the Challenges of Methicillin-Resistant Staphylococcus aureus with Outpatient Parenteral Antimicrobial Therapy 15 September 2010 pp. S171-S230
    9. No. 5 1 September 2010 pp. i-iv, 485-640
    10. No. 4 15 August 2010 pp. i-iv, 371-484
    11. No. 3 1 August 2010 pp. i-iv, 259-370
    12. Supplement 1. Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia 1 August 2010 pp. S1-S170
    13. No. 2 15 July 2010 pp. i-iv, 123-258
    14. No. 1 1 July 2010 pp. i-iv, 1-122
  18. 2010 (Vol. 50)
    1. No. 12 15 June 2010 pp. i-iv, 1551-1704
    2. No. 11 1 June 2010 pp. i-iv, 1433-1550
    3. No. 10 15 May 2010 pp. i-iv, 1331-1431
    4. No. 9 1 May 2010 pp. i-iv, 1205-1329
    5. Supplement 3. Synergistic Pandemics: Confronting the Global HIV and Tuberculosis Epidemics 15 May 2010 pp.
    6. No. 8 15 April 2010 pp. i-iv, 1081-1204
    7. No. 7 1 April 2010 pp. i-iv, 945-1079
    8. No. 6 15 March 2010 pp. i-iv, 797-944
    9. No. 5 1 March 2010 pp. i-iv, 625-795
    10. Supplement 2. Immunization to Prevent Meningococcal Disease: Yesterday, Today, and Tomorrow 1 March 2010 pp. S35-S65
    11. No. 4 15 February 2010 pp. i-iv, 459-624
    12. No. 3 1 February 2010 pp. i-iv, 291-457
    13. Supplement 1. Symposium in Honor of the Memory of Francis P. Tally, MD, Held at Tufts Medical Center and Tufts University School of Medicine, 11 June 2007 1 February 2010 pp. S1-S33
    14. No. 2 15 January 2010 pp. i-iv, 133-289
    15. No. 1 1 January 2010 pp. i-iv, 1-131
2000s
1990s